Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,847,400 | 1,604,000 | 829,400 | 575,100 | 797,900 |
| Marketable Securities | 1,502,400 | 665,700 | 712,900 | 518,400 | 613,900 |
| Receivables | 2,495,700 | 2,351,500 | 2,094,300 | 1,736,900 | 1,545,500 |
| Inventories | 1,872,500 | 1,660,900 | 1,641,700 | 1,182,600 | 991,300 |
| Other current assets | 899,500 | 639,600 | 456,300 | 386,700 | 362,200 |
| TOTAL | $8,617,500 | $6,921,700 | $5,734,600 | $4,399,700 | $4,310,800 |
| Non-Current Assets | |||||
| PPE Net | 5,269,100 | 5,296,300 | 4,894,600 | 4,271,100 | 3,504,500 |
| Investments And Advances | 1,969,600 | 1,416,900 | 1,779,900 | 1,415,600 | 1,043,700 |
| Other Non-Current Assets | 7,975,600 | 8,221,700 | 7,518,400 | 999,600 | 639,500 |
| TOTAL | $15,214,300 | $14,934,900 | $14,192,900 | $6,686,300 | $5,187,700 |
| Total Assets | $23,831,800 | $21,856,600 | $19,927,500 | $11,086,000 | $9,498,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 423,100 | 0 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 3,105,200 | 2,715,400 | 2,378,300 | 1,461,900 | 1,400,400 |
| Other current liabilities | 418,200 | 380,000 | 351,000 | 286,400 | 243,800 |
| TOTAL | $5,689,500 | $5,448,600 | $5,895,700 | $3,617,300 | $2,814,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,372,800 | 1,145,900 | 1,120,800 | 495,700 | 493,700 |
| Other Non-Current Liabilities | 2,286,300 | 1,208,800 | 1,144,400 | 627,100 | 594,600 |
| TOTAL | $6,406,600 | $5,269,000 | $4,010,100 | $2,465,800 | $1,768,000 |
| Total Liabilities | $12,096,100 | $10,717,600 | $9,905,800 | $5,456,000 | $4,582,300 |
| Shareholders' Equity | |||||
| Common Shares | 4,742,500 | 4,667,800 | 4,576,500 | 204,700 | 185,700 |
| Retained earnings | 12,740,600 | 10,942,000 | 9,393,200 | 8,466,000 | 7,588,700 |
| Other shareholders' equity | -400 | 200 | 0 | 200 | -200 |
| TOTAL | $11,735,700 | $11,139,000 | $10,021,700 | $5,002,900 | $4,916,200 |
| Total Liabilities And Equity | $23,831,800 | $21,856,600 | $19,927,500 | $10,458,900 | $9,498,500 |